{"id":10979,"date":"2026-11-19T15:16:20","date_gmt":"2026-11-19T20:16:20","guid":{"rendered":"https:\/\/type1support.ca\/?p=10979"},"modified":"2026-11-19T15:18:56","modified_gmt":"2026-11-19T20:18:56","slug":"screening-for-type-1-diabetes-the-pros-and-cons","status":"publish","type":"post","link":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/","title":{"rendered":"Screening for type 1 diabetes: the pros and cons"},"content":{"rendered":"\n<p>What if type 1 diabetes (T1D) could be detected long before the first symptoms appear or blood glucose levels become elevated?<\/p>\n\n\n\n<p>This has been possible for several years through blood tests that detect autoantibodies, which are markers indicating that the <a href=\"https:\/\/type1support.ca\/en\/type-1-diabetes-and-the-six-missing-hormones\/\">immune system<\/a> is attacking the insulin-producing cells in the pancreas.<\/p>\n\n\n\n<p>What has changed over the years is our understanding of the natural progression of T1D. We now have a better understanding of how to interpret the presence of these autoantibodies, how they evolve over time, and how to identify the different stages of the disease, long before symptoms appear. These advances have renewed interest in screening, which could help people prepare for a potential diagnosis, prevent certain complications (e.g., <a href=\"https:\/\/type1support.ca\/en\/diabetic-ketoacidosis-understanding-it-to-better-protect-yourself\/\">diabetic ketoacidosis<\/a>) and, thanks to recent therapeutic advances, delay the onset of the disease.<\/p>\n\n\n\n<p>But is knowing in advance that you are at risk of developing T1D necessarily a good thing? What are the benefits of screening? And what are some of the less positive aspects to consider?<\/p>\n\n\n\n<p>There is no single answer. Here are some points to help you better understand the pros and cons of screening for type 1 diabetes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:40px\"><strong>First, what is screening for type 1 diabetes?<\/strong><\/h2>\n\n\n\n<p>It is important to understand the difference between <strong>screening<\/strong> and <strong>diagnosis<\/strong>.<\/p>\n\n\n\n<p><strong>Screening<\/strong> helps identify signs that a <a href=\"https:\/\/type1better.com\/en\/type-1-diabetes-screening-yay-or-nay\/\">person may develop T1D<\/a>, even if they have no symptoms. This is done through a blood test that looks for autoantibodies.<\/p>\n\n\n\n<p>However, the presence of autoantibodies does not mean that the person will develop T1D immediately. The level of risk varies, in part, according to the number of autoantibodies detected.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>One autoantibody:<\/strong> The risk of developing T1D is higher than in the general population, but remains relatively low. Approximately 15% of people with a single autoantibody will develop the disease during their lifetime.<\/li>\n\n\n\n<li><strong>Two or more autoantibodies:<\/strong> The risk becomes much higher. When their presence is confirmed, the lifetime risk of developing T1D approaches 100%. This means that the process leading to the disease is already underway, even if blood glucose levels are still normal and the person has no symptoms. This is referred to as stage 1 T1D.<\/li>\n<\/ul>\n\n\n\n<p>If blood glucose levels begin to show abnormalities, the disease has progressed to stage 2. The person may still have no symptoms, but the disease is progressing.<\/p>\n\n\n\n<p>T1D therefore generally progresses through several stages, which are distinguished by the presence of autoantibodies, changes in blood glucose levels and, eventually, the appearance of symptoms.<\/p>\n\n\n\n<div class=\"wp-block-wpdatatables-wpdatatables-gutenberg-block\">\n<div class=\"wpdt-c row wpDataTableContainerSimpleTable wpDataTables wpDataTablesWrapper\n\"\n    >\n        <table id=\"wpdtSimpleTable-120\"\n           style=\"border-collapse:collapse;\n                   border-spacing:0px;\"\n           class=\"wpdtSimpleTable wpDataTable\"\n           data-column=\"3\"\n           data-rows=\"4\"\n           data-wpID=\"120\"\n           data-responsive=\"0\"\n           data-has-header=\"0\">\n\n                    <tbody>        <tr class=\"wpdt-cell-row \" >\n                            <td class=\"wpdt-cell wpdt-bold wpdt-fs-000015\"\n                                    data-cell-id=\"A1\"\n                data-col-index=\"0\"\n                data-row-index=\"0\"\n                style=\" width:11.574074074074%;                padding:10px;\n                \"\n                >\n                                Stage                <\/td>\n                                            <td class=\"wpdt-cell wpdt-bold wpdt-fs-000015\"\n                                    data-cell-id=\"B1\"\n                data-col-index=\"1\"\n                data-row-index=\"0\"\n                style=\" width:34.606481481481%;                padding:10px;\n                \"\n                >\n                                What is happening                <\/td>\n                                            <td class=\"wpdt-cell wpdt-bold wpdt-fs-000015\"\n                                    data-cell-id=\"C1\"\n                data-col-index=\"2\"\n                data-row-index=\"0\"\n                style=\" width:53.819444444444%;                padding:10px;\n                \"\n                >\n                                Blood glucose levels and symptoms                <\/td>\n                                        <\/tr>\n                            <tr class=\"wpdt-cell-row \" >\n                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"A2\"\n                data-col-index=\"0\"\n                data-row-index=\"1\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Stage 1                <\/td>\n                                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"B2\"\n                data-col-index=\"1\"\n                data-row-index=\"1\"\n                style=\"                padding:10px;\n                \"\n                >\n                                At least two autoantibodies are detected. The immune system is attacking the insulin-producing cells in the pancreas.                <\/td>\n                                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"C2\"\n                data-col-index=\"2\"\n                data-row-index=\"1\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Blood glucose levels are still normal. No symptoms.                <\/td>\n                                        <\/tr>\n                            <tr class=\"wpdt-cell-row \" >\n                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"A3\"\n                data-col-index=\"0\"\n                data-row-index=\"2\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Stage 2                <\/td>\n                                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"B3\"\n                data-col-index=\"1\"\n                data-row-index=\"2\"\n                style=\"                padding:10px;\n                \"\n                >\n                                The autoimmune response continues, and the insulin-producing cells are increasingly affected.                <\/td>\n                                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"C3\"\n                data-col-index=\"2\"\n                data-row-index=\"2\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Abnormal blood glucose levels, but no clinical symptoms.                <\/td>\n                                        <\/tr>\n                            <tr class=\"wpdt-cell-row \" >\n                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"A4\"\n                data-col-index=\"0\"\n                data-row-index=\"3\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Stage 3                <\/td>\n                                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"B4\"\n                data-col-index=\"1\"\n                data-row-index=\"3\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Type 1 diabetes becomes clinically apparent. Insulin production is no longer sufficient to meet the body's needs.                <\/td>\n                                            <td class=\"wpdt-cell \"\n                                    data-cell-id=\"C4\"\n                data-col-index=\"2\"\n                data-row-index=\"3\"\n                style=\"                padding:10px;\n                \"\n                >\n                                Blood glucose levels reach diagnostic thresholds. Symptoms may appear (intense thirst, frequent urination, fatigue and weight loss).                <\/td>\n                                        <\/tr>\n                    <\/table>\n<\/div><style id='wpdt-custom-style-120'>\n.wpdt-fs-000015 { font-size: 15px !important;}\n<\/style>\n<style>\n\n\/* td inner border color *\/\n.wpdt-c.wpDataTablesWrapper table.wpDataTable.wpdtSimpleTable td,\n.wpdt-c .wpDataTablesWrapper table.wpDataTable td {\n\tborder-color: #E6E7E8 !important;\n}\n    \/* table outer border color *\/\n.wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr:last-child td,\n.wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr:last-child td.wpdt-merged-cell:last-child,\n.wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr:last-child td.wpdt-merged-cell,\n.wpdt-c .wpDataTablesWrapper table.wpDataTable tr:last-child td {\n\tborder-bottom-color: #E6E7E8 !important;\n}\n.wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr td:first-child,\n.wpdt-c .wpDataTablesWrapper table.wpDataTable tr td:first-child {\n\tborder-left-color: #E6E7E8 !important;\n}\n.wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr td:last-child,\n.wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr td.wpdt-merged-cell:last-child,\n.wpdt-c .wpDataTablesWrapper table.wpDataTable tr td:last-child {\n\tborder-right-color: #E6E7E8 !important;\n}\n                        .wpdt-c.wpDataTablesWrapper table.wpdtSimpleTable tr:first-child td {\n                border-top-color: #E6E7E8 !important;\n            }\n            \n<\/style>\n<\/div>\n\n\n\n<p>The rate of progression varies from person to person. It is difficult to predict and depends on several factors, including the person&#8217;s age and the type of autoantibodies detected. Additional blood tests and regular follow-up may therefore be needed to monitor how the disease progresses.<\/p>\n\n\n\n<p><strong>Diagnosis<\/strong>, on the other hand, confirms the presence of diabetes when blood tests reveal abnormal blood glucose levels. It also determines the type of diabetes. In the case of T1D, insulin treatment generally needs to begin at this stage.<\/p>\n\n\n\n<p>In short, screening helps detect early signs of T1D and monitor its progression before symptoms appear, while diagnosis confirms that diabetes is present.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:39px\"><strong>The pros: why consider screening?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>1. Reducing the risk of diabetic ketoacidosis at diagnosis<\/strong><\/h3>\n\n\n\n<p>Screening makes it possible to identify people at risk and offer them medical follow-up. This may reduce the likelihood of T1D being discovered during an emergency room visit, particularly following an episode of <a href=\"https:\/\/type1support.ca\/en\/diabetic-ketoacidosis-understanding-it-to-better-protect-yourself\/\">diabetic ketoacidosis<\/a>, a serious complication caused by a lack of insulin.<\/p>\n\n\n\n<p>Studies also suggest that avoiding diabetic ketoacidosis and prolonged, severely elevated blood glucose levels at diagnosis may help preserve the insulin-producing cells in the pancreas that are still functioning. This could offer some benefits for diabetes management in the short and medium term, although this period is often still marked by numerous adjustments and a degree of unpredictability.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>2. Having time to prepare and receive better support<\/strong><\/h3>\n\n\n\n<p>Learning that you are at high risk of developing T1D provides an opportunity to gradually learn about the disease and prepare, rather than having to figure everything out at the <a href=\"https:\/\/type1support.ca\/5-cles-essentielles-pour-le-diabete-de-type-1-des-le-diagnostic\/?utm_source=chatgpt.com\">time of <\/a><a href=\"https:\/\/type1support.ca\/en\/five-essential-tips-for-life-with-type-1-diabetes-from-diagnosis-on\/\">d<\/a><a href=\"https:\/\/type1support.ca\/5-cles-essentielles-pour-le-diabete-de-type-1-des-le-diagnostic\/?utm_source=chatgpt.com\">iagnosis<\/a>.<\/p>\n\n\n\n<p>For individuals and their families, this is an opportunity to start learning about T1D and what it involves, ask questions, find resources, and become familiar with available treatments and technologies.<\/p>\n\n\n\n<p>Screening may also help establish a connection with a healthcare team before symptoms appear. Appropriate follow-up can help people recognize the early signs of the disease, better anticipate its progression and reduce the risk of complications at diagnosis.<\/p>\n\n\n\n<p>This preparation may also make the transition to insulin treatment easier. In some situations, insulin therapy can be introduced gradually, starting with one injection and progressively increasing the number of injections as insulin-producing cells are lost. This could give people more time to adjust to their new reality, whether at home, at school or at work.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>3. Accessing treatments that can delay the onset of the disease<\/strong><\/h3>\n\n\n\n<p>Research advances have made it possible to consider interventions before symptoms appear. Teplizumab, for example, is a <a href=\"https:\/\/type1support.ca\/en\/a-new-drug-to-prevent-and-delay-the-onset-of-type-1-diabetes\/\">treatment that can delay the onset of clinical T1D<\/a> by an average of approximately two years in certain people who meet the eligibility criteria.<\/p>\n\n\n\n<p>It does not cure T1D or permanently prevent it from developing, but it represents an important step forward towards treatments that may modify the course of the disease.<\/p>\n\n\n\n<p>Screening can therefore help identify people who may benefit from these treatments or be eligible to participate in clinical trials.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>4. Getting answers and, sometimes, reassurance<\/strong><\/h3>\n\n\n\n<p>When someone has T1D themselves or has a child who has been diagnosed, they may want to know the risk of other family members developing the disease (e.g., other children, grandchildren, brothers and sisters).<\/p>\n\n\n\n<p>A negative result can be reassuring, as it indicates that none of the autoantibodies included in the test were detected at the time of testing. However, a negative result does not guarantee that autoantibodies will not appear later. Risk can change over time, and repeat screening may be considered depending on the circumstances.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>5. Avoiding confusion between type 1 and type 2 diabetes in adults<\/strong><\/h3>\n\n\n\n<p>There is still a common misconception that T1D only affects children and adolescents. However, T1D can develop at any age, including adulthood.<\/p>\n\n\n\n<p>Since type 2 diabetes (T2D) is much more common in adults, T1D is not always considered when abnormal blood glucose levels are detected. As a result, some people may be incorrectly diagnosed with T2D and offered treatment that is not appropriate for their type of diabetes.<\/p>\n\n\n\n<p>Screening for T1D before symptoms appear can help identify people at risk and guide further investigations if a diagnosis is eventually made. It may therefore help reduce confusion between the two types of diabetes and support appropriate care.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:40px\"><strong>The cons: why might someone prefer not to know?<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>1. Living with uncertainty<\/strong><\/h3>\n\n\n\n<p>A positive result does not make it possible to know with certainty whether someone will develop T1D or when it might happen. Test results may also need to be confirmed. This uncertainty can be a source of anxiety, both for the person concerned and for their loved ones.<\/p>\n\n\n\n<p>Some people may also feel tempted to change their diet or physical activity after receiving a positive result. However, no lifestyle changes have been shown to prevent the development of T1D. Screening therefore provides information about risk, but it cannot predict with certainty what will happen next.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>2. Waiting for the disease to develop<\/strong><\/h3>\n\n\n\n<p>Knowing that you may develop T1D, without knowing whether it will happen or when, can be difficult. This uncertainty may lead some people to worry about the future, constantly watch for the first signs of the disease, or feel as though they are simply waiting for it to appear.<\/p>\n\n\n\n<p>The psychological burden can be particularly significant for children and adolescents, who must cope with this uncertainty while they are still growing up.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>3. Having to undergo additional tests<\/strong><\/h3>\n\n\n\n<p>A positive result may require additional blood tests and regular appointments to monitor changes in risk and detect the onset of the disease as early as possible.<\/p>\n\n\n\n<p>Although this follow-up can help ensure that people receive appropriate support, it can also represent an additional burden for them and their families.<\/p>\n\n\n\n<p>Furthermore, a negative result, particularly when obtained during childhood, does not guarantee that autoantibodies will not appear later. Additional tests may therefore be recommended over time, which can also prolong feelings of uncertainty and anxiety.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>4. Concerns about privacy<\/strong><\/h3>\n\n\n\n<p>Some people may wonder who will have access to their results and whether these results could have consequences for their insurance coverage or employment. It is therefore important to understand how this information will be protected.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:39px\"><strong>Beyond individual choice: is screening everyone possible?<\/strong><\/h2>\n\n\n\n<p>The benefits and drawbacks of screening do not concern individuals and families alone. They also raise important questions for our healthcare system.<\/p>\n\n\n\n<p>Currently, research programs such as <a href=\"https:\/\/trialnet.org\/?utm_source=chatgpt.com\">TrialNet<\/a> primarily focus on relatives of people living with T1D, who have a higher risk of developing the disease than the general population.<\/p>\n\n\n\n<p>However, approximately 80\u201390% of people who develop T1D have no family history of the disease. Screening only within families affected by T1D therefore cannot identify the majority of future cases.<\/p>\n\n\n\n<p>Offering screening to the entire population could help identify more people at risk, but would require substantial resources.<\/p>\n\n\n\n<p>Who would be responsible for following up with people who receive a positive result? Are healthcare professionals sufficiently trained? Would everyone have equal access to the same tests, treatments and psychosocial support?<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:39px\"><strong>FEDERATE: contributing to the discussion<\/strong><\/h2>\n\n\n\n<p>Research projects are underway to help <a href=\"https:\/\/type1better.com\/en\/support-through-screening-co-creating-a-screening-program-for-type-1-diabetes\/\">better understand the issues surrounding screening<\/a> and contribute to the development of new approaches.<\/p>\n\n\n\n<p>In Quebec, the FEDERATE project, conducted at the Montreal Clinical Research Institute (IRCM), focuses on <a href=\"https:\/\/type1better.com\/en\/support-through-screening-co-creating-a-screening-program-for-type-1-diabetes\/\">screening for T1D among relatives of people living with the condition<\/a>. Its goal is to assess the feasibility of and participation in a screening program for adult first-degree relatives.<\/p>\n\n\n\n<p>The project is open to people aged 18 to 65 who live in Quebec, do not have diabetes, and have a parent, brother or sister with T1D. By participating, eligible individuals help researchers better understand how to organize a screening and follow-up program that meets families&#8217; needs.<\/p>\n\n\n\n<p>To learn more about the project and how to participate: <a href=\"https:\/\/federate-t1d.com\/en\/\">https:\/\/federate-t1d.com\/<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:39px\"><strong>So, to screen or not to screen?<\/strong><\/h2>\n\n\n\n<p>There is no single answer. For some people, knowing their risk provides an opportunity to prepare and receive better support. For others, this information may feel too uncertain to allow them to take any concrete action and may instead become an additional source of anxiety.<\/p>\n\n\n\n<p>Some people may also wonder what the point is of knowing their risk if they cannot access treatment that could delay the onset of T1D, particularly because of its high cost or the lack of coverage under their government insurance plan. Their decision not to undergo screening is just as valid.<\/p>\n\n\n\n<p>What matters is that everyone has the opportunity to make an informed decision, understanding both what screening can offer and what it involves.<\/p>\n\n\n\n<p>Research continues to evolve. A better understanding of the benefits and consequences of screening will help guide the development of approaches that take into account both the physical health and psychological well-being of the people concerned.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" style=\"font-size:29px\"><strong>References<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Haller, Michael J et al. \u201cISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes.\u201d <em>Hormone Research in Paediatrics<\/em> vol. 97,6 (2024): 529\u2013545. doi:10.1159\/000543035<\/li>\n\n\n\n<li>Ziegler, Anette-Gabriele et al. \u201cInternational consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes: a nominal group technique process.\u201d <em>Diabetologia<\/em> vol. 69,12 (2026): 3370\u20133395. doi:10.1007\/s00125-026-06841-z<\/li>\n<\/ul>\n\n\n\n<p><strong>Written by:<\/strong> Sarah Haag, RN, BSc.<\/p>\n\n\n\n<p><strong>Reviewed by:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Maha Lebbar, MD, MSc.<\/li>\n\n\n\n<li>Delphine Bouchard, RN, BSc.<\/li>\n\n\n\n<li>Claude Laforest, Chlo\u00e9 Freslon, Jacques Pelletier, Aude Bandini, Michel Dostie, patient partners of the <a href=\"https:\/\/type1better.com\/en\/\">BETTER project<\/a>.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What if type 1 diabetes (T1D) could be detected long before the first symptoms appear or blood glucose levels become elevated? This has been possible for several years through blood tests that detect autoantibodies, which are markers indicating that the immune system is attacking the insulin-producing cells in the pancreas. What has changed over the [&hellip;]<\/p>\n","protected":false},"author":515,"featured_media":10973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[4271,4265],"tags":[],"class_list":["post-10979","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diabetes-in-general","category-other-situations","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Screening for type 1 diabetes: the pros and cons - Support<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Screening for type 1 diabetes: the pros and cons - Support\" \/>\n<meta property=\"og:description\" content=\"What if type 1 diabetes (T1D) could be detected long before the first symptoms appear or blood glucose levels become elevated? This has been possible for several years through blood tests that detect autoantibodies, which are markers indicating that the immune system is attacking the insulin-producing cells in the pancreas. What has changed over the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\" \/>\n<meta property=\"og:site_name\" content=\"Support\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-19T20:16:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-19T20:18:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1400\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"type1support\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"type1support\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\"},\"author\":{\"name\":\"type1support\",\"@id\":\"https:\/\/type1support.ca\/#\/schema\/person\/2bd5e78bea1d6e39fe1e5d8c7bca495b\"},\"headline\":\"Screening for type 1 diabetes: the pros and cons\",\"datePublished\":\"2026-11-19T20:16:20+00:00\",\"dateModified\":\"2026-11-19T20:18:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\"},\"wordCount\":1976,\"publisher\":{\"@id\":\"https:\/\/type1support.ca\/#organization\"},\"image\":{\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png\",\"articleSection\":[\"Diabetes in general\",\"Other Situations\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\",\"url\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\",\"name\":\"Screening for type 1 diabetes: the pros and cons - Support\",\"isPartOf\":{\"@id\":\"https:\/\/type1support.ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png\",\"datePublished\":\"2026-11-19T20:16:20+00:00\",\"dateModified\":\"2026-11-19T20:18:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage\",\"url\":\"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png\",\"contentUrl\":\"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png\",\"width\":1400,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/type1support.ca\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Screening for type 1 diabetes: the pros and cons\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/type1support.ca\/#website\",\"url\":\"https:\/\/type1support.ca\/\",\"name\":\"Type1Support\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/type1support.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/type1support.ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/type1support.ca\/#organization\",\"name\":\"Type1Support\",\"url\":\"https:\/\/type1support.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/type1support.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/type1support.ca\/wp-content\/uploads\/2025\/03\/logo_support.png\",\"contentUrl\":\"https:\/\/type1support.ca\/wp-content\/uploads\/2025\/03\/logo_support.png\",\"width\":253,\"height\":64,\"caption\":\"Type1Support\"},\"image\":{\"@id\":\"https:\/\/type1support.ca\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/type1support.ca\/#\/schema\/person\/2bd5e78bea1d6e39fe1e5d8c7bca495b\",\"name\":\"type1support\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/type1support.ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f6aeb9d5de5eeabba16666b41047bd5?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f6aeb9d5de5eeabba16666b41047bd5?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g\",\"caption\":\"type1support\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Screening for type 1 diabetes: the pros and cons - Support","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/","og_locale":"en_US","og_type":"article","og_title":"Screening for type 1 diabetes: the pros and cons - Support","og_description":"What if type 1 diabetes (T1D) could be detected long before the first symptoms appear or blood glucose levels become elevated? This has been possible for several years through blood tests that detect autoantibodies, which are markers indicating that the immune system is attacking the insulin-producing cells in the pancreas. What has changed over the [&hellip;]","og_url":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/","og_site_name":"Support","article_published_time":"2026-11-19T20:16:20+00:00","article_modified_time":"2026-11-19T20:18:56+00:00","og_image":[{"width":1400,"height":675,"url":"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png","type":"image\/png"}],"author":"type1support","twitter_card":"summary_large_image","twitter_misc":{"Written by":"type1support","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#article","isPartOf":{"@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/"},"author":{"name":"type1support","@id":"https:\/\/type1support.ca\/#\/schema\/person\/2bd5e78bea1d6e39fe1e5d8c7bca495b"},"headline":"Screening for type 1 diabetes: the pros and cons","datePublished":"2026-11-19T20:16:20+00:00","dateModified":"2026-11-19T20:18:56+00:00","mainEntityOfPage":{"@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/"},"wordCount":1976,"publisher":{"@id":"https:\/\/type1support.ca\/#organization"},"image":{"@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage"},"thumbnailUrl":"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png","articleSection":["Diabetes in general","Other Situations"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/","url":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/","name":"Screening for type 1 diabetes: the pros and cons - Support","isPartOf":{"@id":"https:\/\/type1support.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage"},"image":{"@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage"},"thumbnailUrl":"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png","datePublished":"2026-11-19T20:16:20+00:00","dateModified":"2026-11-19T20:18:56+00:00","breadcrumb":{"@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#primaryimage","url":"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png","contentUrl":"https:\/\/type1support.ca\/wp-content\/uploads\/2026\/11\/Bannieres-de-blog-23.png","width":1400,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/type1support.ca\/en\/screening-for-type-1-diabetes-the-pros-and-cons\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/type1support.ca\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Screening for type 1 diabetes: the pros and cons"}]},{"@type":"WebSite","@id":"https:\/\/type1support.ca\/#website","url":"https:\/\/type1support.ca\/","name":"Type1Support","description":"","publisher":{"@id":"https:\/\/type1support.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/type1support.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/type1support.ca\/#organization","name":"Type1Support","url":"https:\/\/type1support.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/type1support.ca\/#\/schema\/logo\/image\/","url":"https:\/\/type1support.ca\/wp-content\/uploads\/2025\/03\/logo_support.png","contentUrl":"https:\/\/type1support.ca\/wp-content\/uploads\/2025\/03\/logo_support.png","width":253,"height":64,"caption":"Type1Support"},"image":{"@id":"https:\/\/type1support.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/type1support.ca\/#\/schema\/person\/2bd5e78bea1d6e39fe1e5d8c7bca495b","name":"type1support","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/type1support.ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f6aeb9d5de5eeabba16666b41047bd5?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f6aeb9d5de5eeabba16666b41047bd5?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g","caption":"type1support"}}]}},"category_colors":{"4271":"#978bfc","4265":"#bfb8fd"},"_links":{"self":[{"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/posts\/10979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/users\/515"}],"replies":[{"embeddable":true,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/comments?post=10979"}],"version-history":[{"count":3,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/posts\/10979\/revisions"}],"predecessor-version":[{"id":10982,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/posts\/10979\/revisions\/10982"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/media\/10973"}],"wp:attachment":[{"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/media?parent=10979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/categories?post=10979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/type1support.ca\/en\/wp-json\/wp\/v2\/tags?post=10979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}